The Latest Breaking News from FDA

Incyte stock tumbled to a nearly five-year low Monday after GSK gained FDA approval for a rival myelofibrosis treatment.

Novo Nordisk stock skidded Monday on reports an inspection turned up "objectionable conditions" at a diabetes and weight-loss drugs manufacturing plant.

Diseases that run in families usually have genetic causes. Some are genetic mutations that directly cause the disease if inherited. Others are risk genes that affect the body in a way that increases the chance someone will develop the disease. In Alzheimer’s disease, genetic mutations in any of three specific…

The big names behind biotech stocks no longer want to merely treat diseases, they want to cure them. But it's going to be costly.

The virus sometimes causes severe illness even in those without underlying conditions, including deaths in children

DeSantis cited a conspiracy theory that global health authorities are using people who choose vaccination as ‘guinea pigs’

The debate over how to address drug shortages threatens the reauthorization of a key pandemic preparedness law expiring Sept. 30.

For a history-making two months, a pig's kidney worked normally inside a brain-dead man

Alnylam stock tumbled Thursday after a split advisory panel recommended the Food and Drug Administration approve its heart disease treatment.